Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bjarni Thjodleifsson, Hulda Asbjörnsdottir, Rúna Björg Sigurjonsdottir, Davíd Gíslason, Ísleifur Olafsson, Elizabet Cook, Thorarinn Gíslason, Rain Jogi & Christer Janson. (2007) Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland, Estonia and Sweden. Scandinavian Journal of Infectious Diseases 39:8, pages 683-689.
Read now
Read now
A. Munk Petersen. (2000) Phenotypic and Genotypic Characterization of Helicobacter pylori from Patients with and without Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 35:4, pages 359-367.
Read now
Read now
Articles from other publishers (36)
Hui Jiang, Jiming Gu, Jun Du, Xiaowei Qi, Chengjia Qian & Bojian Fei. (2019) A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer. Molecular Medicine Reports.
Crossref
Crossref
Munther Alomari, Muhammad Taha, Syahrul Imran, Waqas Jamil, Manikandan Selvaraj, Nizam Uddin & Fazal Rahim. (2019) Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease. Bioorganic Chemistry 92, pages 103235.
Crossref
Crossref
Jalal B Jalaly, Marc Roger Couturier, Carey-Ann D Burnham, Ann M Gronowski, Satish Munigala & Elitza S Theel. (2018)
Multicenter Evaluation of
Helicobacter pylori
IgG Antibody Seroprevalence Among Patients Seeking Clinical Care in the US
. The Journal of Applied Laboratory Medicine 2:6, pages 904-913.
Crossref
Crossref
Roshni Bhudia, Amar Ahmad, Onyinye Akpenyi, Angela Whiley, Mark Wilks & Tim Oliver. (2017) Identification of low oxygen-tolerating bacteria in prostate secretions of cancer patients and discussion of possible aetiological significance. Scientific Reports 7:1.
Crossref
Crossref
Akio Nomoto, Tetsuo Shitara, Masakatsu Shibasaki, Tomoko Mizote, Shinpei Yamashita, Chigusa Hayashi & Masayuki Igarashi. (2015) Identification of self-growth-inhibiting compounds lauric acid and 7-(Z)-tetradecenoic acid from Helicobacter pylori. Microbiology 161:6, pages 1231-1239.
Crossref
Crossref
Ivana Hitkova, Gang Yuan, Florian Anderl, Markus Gerhard, Thomas Kirchner, Simone Reu, Christoph Röcken, Claus Schäfer, Roland M. Schmid, Roger Vogelmann, Matthias P. A. Ebert & Elke Burgermeister. (2013) Caveolin-1 Protects B6129 Mice against Helicobacter pylori Gastritis. PLoS Pathogens 9:4, pages e1003251.
Crossref
Crossref
Manhua Zhang, Haiyang Zhang, Yan Li, Wenqian Qi, Xu Wang & Jiangbin Wang. (2013) Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro. World Journal of Microbiology and Biotechnology 29:3, pages 499-504.
Crossref
Crossref
Farzaneh Nabati, Faraz Mojab, Mehran Habibi-Rezaei, Kowsar Bagherzadeh, Massoud Amanlou & Behnam Yousefi. (2012) Large scale screening of commonly used Iranian traditional medicinal plants against urease activity. DARU Journal of Pharmaceutical Sciences 20:1.
Crossref
Crossref
Marjan Micev & Milena Cosic-Micev. (2011) Pathology and pathobiology of the gastric carcinoma. Acta chirurgica Iugoslavica 58:1, pages 39-52.
Crossref
Crossref
Masahiro Uchida, Yoshiyuki Tsukamoto, Tomohisa Uchida, Yuta Ishikawa, Takayuki Nagai, Naoki Hijiya, Lam Tung Nguyen, Chisato Nakada, Akiko Kuroda, Tadayoshi Okimoto, Masaaki Kodama, Kazunari Murakami, Tsuyoshi Noguchi, Keiko Matsuura, Masato Tanigawa, Masao Seto, Hisao Ito, Toshio Fujioka, Ichiro Takeuchi & Masatsugu Moriyama. (2010)
Genomic profiling of gastric carcinoma
in situ
and adenomas by array-based comparative genomic hybridization
. The Journal of Pathology 221:1, pages 96-105.
Crossref
Crossref
Gregory Y. Lauwers & Amitabh Srivastava. (2007) Gastric Preneoplastic Lesions and Epithelial Dysplasia. Gastroenterology Clinics of North America 36:4, pages 813-829.
Crossref
Crossref
Elisabet Carlsohn & Carol L. Nilsson. 2007. Lectins. Lectins
299
325
.
Yasser M. El Miedany, Manal Baddour, Ihab Ahmed & Houssam Fahmy. (2005) Syndrome de Sjögren : infection concomitante à Helicobacter Pylori et corrélations potentielles avec les paramètres cliniques. Revue du Rhumatisme 72:3, pages 213-220.
Crossref
Crossref
Yasser M. El Miedany, Manal Baddour, Ihab Ahmed & Houssam Fahmy. (2005) Sjogren’s syndrome: concomitant H. Pylori infection and possible correlation with clinical parameters. Joint Bone Spine 72:2, pages 135-141.
Crossref
Crossref
Andreas Munk Petersen & Karen Angeliki Krogfelt. (2003)
Helicobacter pylori
: an invading microorganism? A review
. FEMS Immunology & Medical Microbiology 36:3, pages 117-126.
Crossref
Crossref
T Gulten, N TokyayM Demiray, M Gulten, I Ercan, E Evke, S SardasAE Karakaya. (2016)
The Role of Triple Therapy, Age, Gender and Smoking on the Genotoxic Effects of
Helicobacter Pylori
Infection
. Journal of International Medical Research 30:4, pages 380-385.
Crossref
Crossref
Paul Moayyedi, Anthony TR Axon, Richard Feltbower, Sara Duffett, Will Crocombe, David Braunholtz, ID Gerald Richards, Anthony C Dowell & David Forman. (2002) Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. International Journal of Epidemiology 31:3, pages 624-631.
Crossref
Crossref
John Roboz. 2002. Mass Spectrometry in Cancer Research. Mass Spectrometry in Cancer Research
107
199
.
Jalal Taneera, Anthony P Moran, Sean O Hynes, Hans-Olof Nilsson, Waleed abu Al-Soud & Torkel Wadström. (2002) Influence of activated charcoal, porcine gastric mucin and β-cyclodextrin on the morphology and growth of intestinal and gastric Helicobacter spp.. Microbiology 148:3, pages 677-684.
Crossref
Crossref
J. Mason, A. T. R. Axon, D. Forman, S. Duffett, M. Drummond, W. Crocombe, R. Feltbower, S. Mason, J. Brown & P. Moayyedi. (2002)
The cost‐effectiveness of population
Helicobacter pylori
screening and treatment: a Markov model using economic data from a randomized controlled trial
. Alimentary Pharmacology & Therapeutics 16:3, pages 559-568.
Crossref
Crossref
Gregory Y. Lauwers. (2002) Gastric Dysplasia: Diagnosis and Significance. Pathology Case Reviews 7:1, pages 27-34.
Crossref
Crossref
Mikael E. Craanen & Ernst J. Kuipers. (2001) Advantages and disadvantages of population screening for cancer and surveillance of at-risk groups. Best Practice & Research Clinical Gastroenterology 15:2, pages 211-226.
Crossref
Crossref
A. M. Petersen, K. Sorensen, J. Blom & K. A. Krogfelt. (2001) Reduced intracellular survival of Helicobacter pylori vacA mutants in comparison with their wild-types indicates the role of VacA in pathogenesis. FEMS Immunology & Medical Microbiology 30:2, pages 103-108.
Crossref
Crossref
A.M. Petersen, J. Blom, L.P. Andersen & K.A. Krogfelt. (2000)
Role of strain type, AGS cells and fetal calf serum in
Helicobacter pylori
adhesion and invasion assays
. FEMS Immunology & Medical Microbiology 29:1, pages 59-67.
Crossref
Crossref
Manfred Eberhardt. 2000. Reactive Oxygen Metabolites. Reactive Oxygen Metabolites.
Gianfranco Donelli, Paola Matarrese, Carla Fiorentini, Benedetto Dainelli, Tea Taraborelli, Emanuela Campli, Soraya Bartolomeo & Luigina Cellini. (1998)
The effect of oxygen on the growth and cell morphology of
Helicobacter pylori
. FEMS Microbiology Letters 168:1, pages 9-15.
Crossref
Crossref
Taciana de Figueiredo Soares, Dulciene Maria de Magalhães Queiroz, Edilberto Nogueira Mendes, Gifone Aguiar Rocha, Andréia Maria Rocha Oliveira, Mônica Maria Demas Álvares Cabral & Celso Affonso de Oliveira. (1998) The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma. American Journal of Gastroenterology 93:10, pages 1841-1847.
Crossref
Crossref
Giorgio Minoli, Alberto Prada, Robert Schuman, Daniel Murnick & Basil Rigas. (1998) A Simplified Urea Breath Test for the Diagnosis of Helicobacter pylori Infection Using the LARA System. Journal of Clinical Gastroenterology 26:4, pages 264-266.
Crossref
Crossref
P. Aucher, M. L. Petit, P. R. Mannant, L. Pezennec, P. Babin & J. L. Fauchere. (1998)
Use of Immunoblot Assay To Define Serum Antibody Patterns Associated with
Helicobacter pylori
Infection and with
H. pylori
-Related Ulcers
. Journal of Clinical Microbiology 36:4, pages 931-936.
Crossref
Crossref
L Trevisani, S Sartori, M Caselli, M Ruina, G Verdianelli & V Abbasciano. (1998) A Four-Day Low Dose Triple Therapy Regimen for the Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 93:3, pages 390-393.
Crossref
Crossref
Georg Oberhuber, Thomas Wuendisch, Sigrid Rappel & Manfred Stolte. (1998) Significant Improvement of Atrophy after Eradication Therapy in Atrophic Body Gastritis. Pathology - Research and Practice 194:9, pages 609-613.
Crossref
Crossref
C. J. Schorah. 1998. Vitamin C. Vitamin C
41
49
.
Ken Kimura & Kiichi Satoh. (1997) What Remaining Questions Regarding Helicobacter pylori and Associated Diseases Should Be Addressed by Future Research?. Gastroenterology 113:6, pages S155-S157.
Crossref
Crossref
Paul Moayyedi & Michael F. Dixon. (1997) Significance of Helicobacter Pylori Infection and Gastric Cancer: Implications for Screening. Gastrointestinal Endoscopy Clinics of North America 7:1, pages 47-64.
Crossref
Crossref
H M DaveyD B Kell. (1996) Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses. Microbiological Reviews 60:4, pages 641-696.
Crossref
Crossref
C. J. Hawkey. 1996. Helicobacter pylori. Helicobacter pylori
312
323
.